Image

The Effects of Home-based Graded Repetitive Arm Supplementary Program Group on Stroke.

The Effects of Home-based Graded Repetitive Arm Supplementary Program Group on Stroke.

Recruiting
20 years and older
All
Phase N/A

Powered by AI

Overview

Graded repetitive arm supplementary program (GRASP) is a self administrated, home-based rehabilitation program and has been incorporated in Canadian Stroke Best Practice Recommendations. Past studies indicated that the home-based GRASP program could facilitate the motor function and motor recovery and prevent learned nonuse of affected upper limb of stroke patients. There is lacking of research and application of the home-based GRASP program in Taiwan. Therefore, this study aims to explore the effects of the home-based GRASP program, which is mainly executed in the form of group intervention, on the affected upper limb of stroke patients.

Eligibility

Inclusion Criteria:

  1. Age is above 20 years old.
  2. Onset of first stroke complicated with hemiplegia or hemiparesis.
  3. The affected upper limb remains partially voluntary movements including lifting to chest level and holding for five seconds; slight flexion and extension of wrist and hand.
  4. Understanding and complying with two-steps commands.
  5. Understanding the content of trial and willing to sign informed consent.

Exclusion Criteria:

  1. Complicating with other neurological disease.
  2. Having Orthopedic diseases affecting the movements of upper limbs.
  3. Having symptoms of pain to affect the movements of upper limbs.
  4. Unstable vital sign or medical condition.
  5. Participating another rehabilitative or drug research meanwhile.
  6. Receiving botulinum toxin injection within three months.

Study details
    Stroke

NCT06883357

National Taiwan University Hospital

12 April 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.